Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

Clinical trial NCT07492628 · RECRUITING

Trial details

NCT number: NCT07492628
Sponsor: Beijing Biotech
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Bladder Cancer Urothelial Carcinoma Metastatic Urothelial Carcinoma Locally Advanced Urothelial Carcinoma Upper Tract Urothelial Carcinoma

Start date: 2026-03-02
Primary completion: 2027-06-14
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.